165 related articles for article (PubMed ID: 10946217)
1. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities.
Subbanagounder G; Watson AD; Berliner JA
Free Radic Biol Med; 2000 Jun; 28(12):1751-61. PubMed ID: 10946217
[TBL] [Abstract][Full Text] [Related]
2. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.
Watson AD; Leitinger N; Navab M; Faull KF; Hörkkö S; Witztum JL; Palinski W; Schwenke D; Salomon RG; Sha W; Subbanagounder G; Fogelman AM; Berliner JA
J Biol Chem; 1997 May; 272(21):13597-607. PubMed ID: 9153208
[TBL] [Abstract][Full Text] [Related]
3. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation.
Friedman P; Horkko S; Steinberg D; Witztum JL; Dennis EA
J Biol Chem; 2002 Mar; 277(9):7010-20. PubMed ID: 11744722
[TBL] [Abstract][Full Text] [Related]
4. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211
[TBL] [Abstract][Full Text] [Related]
5. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
[TBL] [Abstract][Full Text] [Related]
6. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.
Watson AD; Subbanagounder G; Welsbie DS; Faull KF; Navab M; Jung ME; Fogelman AM; Berliner JA
J Biol Chem; 1999 Aug; 274(35):24787-98. PubMed ID: 10455151
[TBL] [Abstract][Full Text] [Related]
7. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a role of phospholipid oxidation products in atherogenesis.
Berliner JA; Subbanagounder G; Leitinger N; Watson AD; Vora D
Trends Cardiovasc Med; 2001; 11(3-4):142-7. PubMed ID: 11686004
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis.
Schmitt A; Nègre-Salvayre A; Troly M; Valdiguié P; Salvayre R
Biochim Biophys Acta; 1995 Jun; 1256(3):284-92. PubMed ID: 7786889
[TBL] [Abstract][Full Text] [Related]
10. Bioactive phospholipid oxidation products.
Marathe GK; Harrison KA; Murphy RC; Prescott SM; Zimmerman GA; McIntyre TM
Free Radic Biol Med; 2000 Jun; 28(12):1762-70. PubMed ID: 10946218
[TBL] [Abstract][Full Text] [Related]
11. Oxidized LDL contains inflammatory PAF-like phospholipids.
Marathe GK; Prescott SM; Zimmerman GA; McIntyre TM
Trends Cardiovasc Med; 2001; 11(3-4):139-42. PubMed ID: 11686003
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein oxidation and atherosclerosis.
Young IS; McEneny J
Biochem Soc Trans; 2001 May; 29(Pt 2):358-62. PubMed ID: 11356183
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.
Leeuwenburgh C; Rasmussen JE; Hsu FF; Mueller DM; Pennathur S; Heinecke JW
J Biol Chem; 1997 Feb; 272(6):3520-6. PubMed ID: 9013599
[TBL] [Abstract][Full Text] [Related]
14. Oxidation products of phospholipid-containing delta-9 fatty acids specifically impair the activity of tissue factor pathway inhibitor.
Hiraishi S; Horie S; Seyama Y
Biochem Biophys Res Commun; 2002 Nov; 298(4):468-73. PubMed ID: 12408975
[TBL] [Abstract][Full Text] [Related]
15. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Fonarow GC; Vahabzadeh K; Hama S; Hough G; Kamranpour N; Berliner JA; Lusis AJ; Fogelman AM
J Lipid Res; 2004 Jun; 45(6):993-1007. PubMed ID: 15060092
[TBL] [Abstract][Full Text] [Related]
16. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein.
Chisolm GM; Ma G; Irwin KC; Martin LL; Gunderson KG; Linberg LF; Morel DW; DiCorleto PE
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11452-6. PubMed ID: 7972083
[TBL] [Abstract][Full Text] [Related]
17. p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima.
Heller JI; Crowley JR; Hazen SL; Salvay DM; Wagner P; Pennathur S; Heinecke JW
J Biol Chem; 2000 Apr; 275(14):9957-62. PubMed ID: 10744670
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E oxidation in human atherosclerotic lesions.
Terentis AC; Thomas SR; Burr JA; Liebler DC; Stocker R
Circ Res; 2002 Feb; 90(3):333-9. PubMed ID: 11861423
[TBL] [Abstract][Full Text] [Related]
19. Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.
Ravandi A; Babaei S; Leung R; Monge JC; Hoppe G; Hoff H; Kamido H; Kuksis A
Lipids; 2004 Feb; 39(2):97-109. PubMed ID: 15134136
[TBL] [Abstract][Full Text] [Related]
20. Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region.
Ohkura N; Hiraishi S; Itabe H; Hamuro T; Kamikubo Y; Takano T; Matsuda J; Horie S
Antioxid Redox Signal; 2004 Aug; 6(4):705-12. PubMed ID: 15242551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
